HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients.

Abstract
Since a striking association between hepatitis C virus (HCV) infection and mixed cryoglobulinemia has been demonstrated, the aim of this study is to investigate the effect of alpha-interferon (alpha-IFN) on HCV viraemia and clinico-serological manifestations of 15 patients (ten female and five male, mean [+/- SD] age 53 +/- 7 years). In 14/15 patients pre-study steroid dosage remained unchanged during treatment. alpha-IFN was administered at a dose of 2 x 10(6) IU daily for a month, then every other day for five months. On the whole, a statistically significant improvement of purpura (p < 0.001), serum transaminases (p < 0.001), and cryocrit (p < 0.01) was observed after alpha-IFN treatment. HCV viraemia was detected by polymerase chain reaction technique in 13/15 patients with mixed cryoglobulinemia and anti-GOR antibodies, expression of HCV-related autoimmunity, were present in 8/15. After alpha-IFN treatment, HCV RNA levels showed a clear-cut reduction in five persons and disappeared in another, while anti-HCV antibodies (Chiron ELISA and RIBA II) did not change after the six-month period of therapy. These data further support the possible etiopathogenetic role of HCV in patients with mixed cryoglobulinemia and suggest that alpha-IFN may be regarded as the elective treatment in this disease.
AuthorsC Ferri, A L Zignego, G Longombardo, M Monti, L La Civita, F Lombardini, F Greco, A Mazzoni, G Pasero, P Gentilini
JournalInfection (Infection) 1993 Mar-Apr Vol. 21 Issue 2 Pg. 93-7 ISSN: 0300-8126 [Print] Germany
PMID7684029 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hepatitis Antibodies
  • Hepatitis C Antibodies
  • Interferon-alpha
Topics
  • Chronic Disease
  • Cryoglobulinemia (complications, immunology)
  • Drug Administration Schedule
  • Female
  • Hepacivirus (immunology, isolation & purification)
  • Hepatitis Antibodies (isolation & purification)
  • Hepatitis C (drug therapy, immunology)
  • Hepatitis C Antibodies
  • Humans
  • Interferon-alpha (pharmacology)
  • Male
  • Middle Aged
  • Viremia (drug therapy, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: